R
R/S Configuration
Definition: CIP-based descriptors assigning absolute configuration to stereocenters.
Context: Universal language for stereochemical specification in pharma and patents.
Example: S-ibuprofen is the active eutomer.
Related Terms: CIP Rules, Absolute Configuration.
Reference: Cahn–Ingold–Prelog rules (1956/1966).
Racemic Compound
Definition: Racemate that crystallizes as a single racemic crystal containing both enantiomers.
Context: Limits simple preferential crystallization; requires alternative resolution routes.
Example: Racemic mandelic acid (context dependent).
Related Terms: Racemate, Conglomerate.
Reference: Eliel & Wilen (1994).
Racemic Drug

Paired Concept:
Chiral Switch
Definition: A pharmaceutical product that contains equal amounts (1:1 ratio) of both enantiomers of a chiral drug,
forming a racemic mixture (racemate).
Context: Many chiral drugs were originally developed and marketed as racemates because synthesizing or separating
individual enantiomers was technically challenging and costly. However, the two enantiomers in a racemic drug may differ
significantly in pharmacological activity, pharmacokinetics, metabolism, toxicity, or side-effect profiles. Advances in
chiral synthesis and regulatory requirements have led to the development of several single-enantiomer versions of
previously marketed racemic drugs, a process known as a chiral switch.
Example: Ibuprofen is marketed as a racemic drug containing both R- and S-ibuprofen. The S-enantiomer is primarily
responsible for the anti-inflammatory activity, while the R-enantiomer undergoes partial metabolic conversion to the
active S-form in vivo.
Related Terms: Racemate, Enantiomer, Enantiopure Drug, Chiral Switch, Eutomer, Distomer, Stereoselectivity.
Reference: Ariens, E. J. (1984). "Stereochemistry, a Basis for Sophisticated Nonsense in Pharmacokinetics and
Clinical Pharmacology." European Journal of Clinical Pharmacology, 26, 663-668; Smith, S. W. (2009). "Chiral Toxicology:
It's the Same Thing... Only Different." Toxicological Sciences, 110(1), 4-30; Nguyen, L. A., He, H., & Pham-Huy, C.
(2006). "Chiral Drugs: An Overview." International Journal of Biomedical Science, 2(2), 85-100; International Union of
Pure and Applied Chemistry. Compendium of Chemical Terminology (Gold Book) - Definitions of racemate, enantiomer, and
chirality-related terms.
Key Distinction
| Term |
Characteristic |
| Racemic Drug |
Contains equal amounts of both enantiomers (50:50); ee = 0%. |
| Enantiopure Drug |
Contains only one enantiomer; ee ? 100%. |
| Enantioenriched Drug |
Contains one enantiomer in excess over the other; 0% < ee < 100%. |
| Chiral Switch |
Development of a single-enantiomer drug from a previously marketed racemic drug. |
Key Insight: A racemic drug is not necessarily inferior to an enantiopure drug. In some cases, both enantiomers
contribute
beneficially to therapeutic activity, whereas in others one enantiomer may be inactive or associated with adverse
effects. Consequently, the choice between a racemate and a single-enantiomer drug depends on scientific, clinical, and
regulatory considerations.
Racemic Mixture (Racemate)

Paired Concept:
Scalemic Mixture |
Enantiopure
Definition: A 1:1 mixture of enantiomers.
Context: Common synthetic outcome; may require resolution or chiral switching.
Example: Racemic thalidomide.
Related Terms: Conglomerate, Racemic Compound.
Reference: FDA Policy on Stereoisomeric Drugs (1992).
Racemization

Paired Concept:
Resolution
Definition: Conversion of an enantiopure substance to a racemate.
Context: Critical risk for chiral APIs and must be controlled in process/storage.
Example: Base-catalyzed racemization of α-chiral carbonyls.
Related Terms: Enantiomerization, Stereomutation.
Reference: IUPAC Gold Book.
Raman Optical Activity (ROA)
Definition: Difference in Raman scattering for circularly polarized light.
Context: Complementary to VCD; sensitive to conformation of chiral molecules and biomacromolecules.
Example: ROA of proteins to assess secondary structure.
Related Terms: VCD, CD.
Reference: Barron, Molecular Light Scattering (2004).
Re/Si Face
Definition: Descriptors for the two faces of a trigonal (sp²) center.
Context: Used to define enantioface selectivity in additions and reductions.
Example: Hydride attack on the Re face of a ketone.
Related Terms: Prochirality, Pro-R/Pro-S.
Reference: IUPAC Gold Book.
Relative Configuration

Paired Concept:
Absolute Configuration Definition: The spatial relationship between stereocenters within a molecule without reference to absolute R/S.
Context: Useful for assigning diastereomer series in synthesis and NMR analysis.
Example: Erythro vs threo in sugars.
Related Terms: Diastereomer, Absolute Configuration.
Reference: Eliel & Wilen (1994).
Relative Stereochemistry
Definition: The spatial relationship between stereocenters within a molecule without reference to absolute configuration.
Context: Important for describing diastereomers in synthesis and structure elucidation.
Example: Erythro and threo configurations of 2,3-butanediols.
Related Terms: Absolute Configuration; Diastereomer; Enantiomer.
Reference: Eliel & Wilen (1994).
Resolution

Paired Concept:
Racemization
Definition: The process of separating a racemic mixture into its individual enantiomers.
Context: A key step in the preparation of enantiopure compounds for pharmaceutical use. Can be achieved through crystallization, chemical or enzymatic methods, or chiral chromatography.
Example: Resolution of racemic mandelic acid using (+)-α-phenylethylamine.
Related Terms: Racemate; Enantiomeric Excess; Chiral HPLC; Kinetic Resolution.
Reference: Jacques, J., Collet, A. & Wilen, S. H. Enantiomers, Racemates, and Resolutions. Wiley, 1981.